Skip to main content

Table 4 Physical function and performance status of the study groups at baseline and week 12a

From: Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial

Outcome Measure

Study group

n

Baseline

Week 12

Difference week 12

p b

p c

Physical function

 SMWT distance [m]

Control

21

484.30 ± 135.0

504.6 ± 116.8

20.3 ± 48.2

0.024

0.036

WB-EMS

51

521.6 ± 104.5

577.1 ± 95.4

55.4 ± 75.2

< 0.001

Performance status

 Karnofsky Index

Control

24

75.4 ± 10.6

73.8 ± 12.1

−1.7 ± 10.5

0.412

0.025

WB-EMS

57

76.4 ± 10.9

81.6 ± 12.4

5.2 ± 11.7

0.002

  1. Statistically significant differences are marked in bold type and indicated by p < 0.05
  2. Abbreviations: SMWT Six-minute walk test, WB-EMS Whole-body electromyostimulation
  3. aIncludes patients with both baseline and post-intervention data. Data are presented as mean ± SD
  4. bComparison of intragroup differences in baseline and post-intervention data (Wilcoxon signed-rank test)
  5. cComparison of differences from baseline to 12-week post-intervention changes between the groups (Mann-Whitney-U-test)